Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition. | Cancers (Basel) | 2022 | 36611998 | PubTator, text mining | PubMed |
| Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis. | Front Immunol | 2022 | 36601107 | PubTator, text mining | PubMed |
| Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims. | Front Cell Dev Biol | 2022 | 36589745 | PubTator, text mining | PubMed |
| Co-Occurring Atypical Galactosemia and Wilson Disease. | Mol Syndromol | 2022 | 36588756 | PubTator, text mining | PubMed |
| Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36588699 | PubTator, text mining | PubMed |
| Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model. | Biomed Res Int | 2022 | 36588537 | PubTator, text mining | PubMed |
| A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. | Cell Biosci | 2022 | 36581992 | PubTator, text mining | PubMed |
| Role of serum ceruloplasmin in the diagnosis of Wilson's disease: A large Chinese study. | Front Neurol | 2022 | 36570465 | PubTator, text mining | PubMed |
| A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients. | Front Pediatr | 2022 | 36568423 | PubTator, text mining | PubMed |
| Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36568234 | PubTator, text mining | PubMed |
| Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma. | Front Oncol | 2022 | 36568224 | PubTator, text mining | PubMed |
| A comprehensive analysis focusing on cuproptosis to investigate its clinical and biological relevance in uterine corpus endometrial carcinoma and its potential in indicating prognosis. | Front Mol Biosci | 2022 | 36567939 | PubTator, text mining | PubMed |
| Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer. | Front Genet | 2022 | 36561322 | PubTator, text mining | PubMed |
| Retinal Degeneration in Patients with Wilson's Disease: An OCT Study in Asian Indian Population. | Ann Indian Acad Neurol | 2022 | 36561027 | PubTator, text mining | PubMed |
| Real-World Results from Combined Screening for Monogenic Genomic Health Risks and Reproductive Risks in 300 Adults. | J Pers Med | 2022 | 36556183 | PubTator, text mining | PubMed |
| Investigating Psychological Impact after Receiving Genetic Risk Results-A Survey of Participants in a Population Genomic Screening Program. | J Pers Med | 2022 | 36556164 | PubTator, text mining | PubMed |
| A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes. | Genes (Basel) | 2022 | 36553628 | PubTator, text mining | PubMed |
| A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas. | Cells | 2022 | 36552841 | PubTator, text mining | PubMed |
| Pseudocholinesterase as a Biomarker for Untreated Wilson's Disease. | Biomolecules | 2022 | 36551217 | PubTator, text mining | PubMed |
| Cuproptosis-associated genes and immune microenvironment characterization in breast cancer. | Medicine (Baltimore) | 2022 | 36550822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=44